1-octacosanol has been researched along with Hyperlipoproteinemia Type II in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gratsianskiĭ, NA; Nechaev, AS; Nikitin, IuP; Poltavskaia, MG; Revazov, AV; Slepchenko, NV; Sumarokov, AV; Syrkin, AL | 1 |
1 trial(s) available for 1-octacosanol and Hyperlipoproteinemia Type II
| Article | Year |
|---|---|
[Results of the multicenter controlled study of the hypolipidemic drug polycosanol in Russia].
Topics: Double-Blind Method; Fatty Alcohols; Female; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Male; Middle Aged; Russia | 2000 |